Voyageur Pharmaceuticals Ltd V.VM

Alternate Symbol(s): VYYRF

Healthcare Drug Manufacturers - Specialty & Generic

Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine Active Pharmaceutical Ingredients (API) and offers high-performance imaging contrast agents. The Company is focused on vertically integrating the barium and iodine contrast market, and aims at producing its own barium, iodine, and endo fullerenes. The Company’s products include SmoothX, SmoothHD, SmoothLD, VisionHD, VisionLD and V-Gas. SmoothX (2%w/v) is a contrast medium for use in computed tomography (CT) of the gastrointestinal tract. VisionHD is a high-density (98% w/w) barium powder suspension tailored for double-contrast radiographic examination of the gastrointestinal tract, esophagus, stomach and duodenum. It also owns a 100% interest in the Frances Creek barium sulfate (barite) project, which is a rare grade mineral suitable for the pharmaceutical marketplace that is intended to replace the current synthetic products with quality imaging products.

TSXV:VM - Post by User

Voyageur Pharmaceuticals Ltd > Financing on the Horizon

<< Previous

Bullboard Posts

Next >>

Post by WarrantOfficeron Oct 20, 2022 9:20am

163 Views

Post# 35035841

Financing on the Horizon

Consolidated Financial Statement ending 31 May 2022 stated approx 250K in cash remaining. One product out of five ready for market. If the new CFO can make institutional financing happen, would make plenty of shareholders very happy. Speed is of the essence here as voids can be filled.

<< Previous

Bullboard Posts

Next >>

Here are three global stocks you should watch